U.S. Customs and Border Protection ruled in June that the redesigned Apple Watch isn’t violating any EKG patents belonging to medical device company AliveCor, Apple Insider reported July 15. Therefore, Apple does not have to pay a bond to import them.
AliveCor first sued Apple over the technology in 2021 but has not succeeded in court. Fellow medtech company Masimo also challenged Apple’s blood-oxygen technology, leading to an import ban and the tech giant to remove the feature from its watch.
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.